These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2760465)

  • 1. A simple method for the biochemical purification of Ro/SS-A antigen.
    Wu DH; Tavoni A; Garzelli C; Neri R; Vitali C; Bombardieri S
    J Immunol Methods; 1989 Jul; 121(2):219-24. PubMed ID: 2760465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A calreticulin-like protein co-purifies with a '60 kD' component of Ro/SSA, but is not recognized by antibodies in Sjögren's syndrome sera.
    Lu J; Willis AC; Sim RB
    Clin Exp Immunol; 1993 Dec; 94(3):429-34. PubMed ID: 8252803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Purification of the Ro/SSA antigen and enzyme-linked immunosorbent assay for quantitation of the antibody].
    Kumagai T; Kato M; Kondo K; Kameko M; Imai H; Kiyosawa K; Katsuyama T; Kanai M
    Ryumachi; 1989 Feb; 29(1):30-8. PubMed ID: 2787055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a solid phase enzyme immunoassay for the detection of anti-Ro autoantibodies.
    Dörner T; Hiepe F; Mielke F; Kiessig ST; Lukowsky A; Apostoloff E
    Scand J Rheumatol; 1991; 20(4):267-73. PubMed ID: 1925414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitive and specific assay to detect Ro(SS-A) and La(SS-B) antibodies.
    Herrera-Esparza R; Halim HY; Provost TT; Diaz LA
    J Invest Dermatol; 1986 Mar; 86(3):217-21. PubMed ID: 3489050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of a quantitative assay for the detection of anti-Ro/SS-A and anti-LA/SS-B autoantibodies using purified recombinant proteins.
    Veldhoven CH; Meilof JF; Huisman JG; Smeenk RJ
    J Immunol Methods; 1992 Jul; 151(1-2):177-89. PubMed ID: 1629608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characteristics of SS-B/La and SS-A/Ro cellular antigens.
    Deng JS; Sontheimer RD; Gilliam JN
    J Invest Dermatol; 1985 Feb; 84(2):86-90. PubMed ID: 3881537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Ro/SS-A antigen in human skin and heart.
    Deng JS; Sontheimer RD; Gilliam JN
    J Invest Dermatol; 1985 Nov; 85(5):412-6. PubMed ID: 3932521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of human Ro/SS-A antigen. Amino terminal sequence of the protein moiety of human Ro/SS-A antigen and immunological activity of a corresponding synthetic peptide.
    Lieu TS; Newkirk MM; Capra JD; Sontheimer RD
    J Clin Invest; 1988 Jul; 82(1):96-101. PubMed ID: 3260607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The demonstration of SS-A/Ro antigen in human fetal tissues and in neonatal and adult skin.
    Lee LA; Harmon CE; Huff JC; Norris DA; Weston WL
    J Invest Dermatol; 1985 Aug; 85(2):143-6. PubMed ID: 3926904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the SS-A/Ro intracellular antigen with autoimmune sera.
    Lieu TS; Jiang M; Steigerwald JC; Tan EM
    J Immunol Methods; 1984 Jul; 71(2):217-28. PubMed ID: 6736660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of Ro(SSA) and La(SSB) proteins.
    Herrera-Esparza R; Provost TT; Diaz LA
    J Rheumatol; 1986 Apr; 13(2):327-30. PubMed ID: 3088274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purified recombinant 60 kD SS-A/Ro protein--an antigenic source for ELISA screening of patients with rheumatic diseases.
    Ben-Chetrit E; Pollard KM
    J Clin Lab Immunol; 1990 Aug; 32(4):195-200. PubMed ID: 1966938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenicity of a recombinant Ro (SS-A) fusion protein.
    James JA; Dickey WD; Fujisaku A; O'Brien CA; Deutscher SL; Keene JD; Harley JB
    Arthritis Rheum; 1990 Jan; 33(1):102-6. PubMed ID: 1689160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies to the Ro/SS-A particle react preferentially with the human antigen.
    Reichlin M; Reichlin MW
    J Autoimmun; 1989 Aug; 2(4):359-65. PubMed ID: 2506878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FPLC and Ro/SS-A purification.
    Tavoni A; Garzelli C; Neri R; Vitali C; Bombardieri S
    Scand J Rheumatol; 1992; 21(2):98. PubMed ID: 1570500
    [No Abstract]   [Full Text] [Related]  

  • 17. Higher incidences of anti-SS-A/Ro and anti-SS-B/La autoantibodies in Japanese patients with autoimmune disorders--studies of antigens and antibodies using the immunoblotting method.
    Inagaki Y; Jinno Y; Hamasaki Y; Ueki H
    Arch Dermatol Res; 1989; 281(2):89-94. PubMed ID: 2774641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of antigenically intact Ro ribonucleoproteins; biochemical and immunological evidence that the 52-kD protein is not a Ro protein.
    Boire G; Gendron M; Monast N; Bastin B; Ménard HA
    Clin Exp Immunol; 1995 Jun; 100(3):489-98. PubMed ID: 7774061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular localization of the Ro/SS-A antigen.
    Lopez-Robles E; Herrera-Esparza R; Avalos-Diaz E
    Clin Rheumatol; 1986 Jan; 5(1):33-8. PubMed ID: 3514080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus: clinical expression and anti-Ro/SS--a response in patients with and without lesions of subacute cutaneous lupus erythematosus.
    López-Longo FJ; Monteagudo I; González CM; Grau R; Carreño L
    Lupus; 1997; 6(1):32-9. PubMed ID: 9116716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.